Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK/PD Study of Fluticasone/Formoterol BAI vs pMDI in Healthy Volunteers
NCT02403713Phase 1Completed
- Sponsor
- Mundipharma
- Start
- Aug 2014
- Primary completion
- Oct 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of fluticasone propionate and formoterol in asthma (5 arms), sponsored by Mundipharma. Primary endpoints: Composite measurement of Pharmacokinetic parameters (Cmax, AUCt, AUCINF) and Serum Potassium. Started Aug 2014; status: completed.
02
Drugs
fluticasone propionateformoterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT02403713.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02403713.